Avanos Medical Inc. (AVNS)
NYSE · Healthcare
Avanos Medical Inc. EBITDA 2012–2025
Avanos Medical Inc. annual/quarterly ebitda history and growth rate from 2012 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Avanos Medical Inc. ebitda for the quarter ending March 31, 2026 was 19.1 M, a 4.02% decrease year-over-year.
- Avanos Medical Inc. ebitda for the twelve months ending March 31, 2026 was 60.4 M, a 403.33% increase year-over-year.
- Avanos Medical Inc. annual ebitda for 2025 was -22.7 M, a 93.53% decrease from 2024.
- Avanos Medical Inc. annual ebitda for 2024 was -350.7 M, a 797.22% decrease from 2023.
- Avanos Medical Inc. annual ebitda for 2023 was 50.3 M, a 39.54% decrease from 2022.
- Avanos Medical Inc. annual ebitda for 2022 was 83.2 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Avanos Medical Inc. EBITDA — FAQ
Avanos Medical Inc. (AVNS) ebitda over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVNS's ebitda history?
The chart and table above show Avanos Medical Inc.'s ebitda by year and by quarter, including the growth rate.